Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C

By Younossi Zobair   McCullough Arthur   Barnes David   Post Anthony   Ong Janus   O’shea Robert   Martin Lisa   Bringman Diane   Farmer Denise   Levinthal Gavin   Mullen Kevin   Carey William   Tavill Anthony   Ferguson Roy   Gramlich Terry  

Digestive Diseases and Sciences, Vol. 50, Iss. 5, 2005-05 ,pp. : 970-975

Springer Publishing Company

Access to resources Recommend Favorite

Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection

By  

Current HIV Research, Vol. 7, Iss. 4, 2009-07 ,pp. : 447-455

Bentham Science Publishers

Access to resources Recommend Favorite

A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C

By Okuse Chiaki   Adachi Kayo   Katakura Yoshiki   Matsunaga Kotaro   Ishii Toshiya   Matsumoto Nobuyuki   Yotsuyanagi Hiroshi   Iino Shiro   Suzuki Michihiro   Itoh Fumio  

Journal of Gastroenterology, Vol. 41, Iss. 12, 2006-12 ,pp. : 1231-1236

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 426-433

Karger

Access to resources Recommend Favorite

Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load

By  

Case Reports in Gastroenterology, Vol. 3, Iss. 3, 2009-11 ,pp. : 372-376

Karger

Access to resources Recommend Favorite